Tomoko Ohtsu - Concepedia

Author

Tomoko Ohtsu

National Cancer Center Hospital East

Also Known As

Tomoko OHTSU, Tomoko Ohtsu, Tomoko Ohtsu *, Tomoko Ohtsu, M.D.

Publications

Citations

H-Index

Concepts

All Affiliations

National Cancer Center Hospital East National Cancer Center Tokyo National Hospital Nagoya University Amgen (United States)

About

Tomoko Ohtsu is an author at National Cancer Center Hospital East specializing in medicine, immunology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	678
2	Immunology	9	9	485
3	Health Sciences	3	3	247
4	Allergy	1	1	10
5	Hepatology	1	1	39

Tomoko Ohtsu

Publications

972

Citations

H-Index

Page 1

	Year	Citations
Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia/Lymphoma: ATLL-002 Takashi Ishida, Hiroshi Fujiwara, Kisato Nosaka, Journal of Clinical Oncology Hematological MalignancyLymphoid NeoplasiaMedicineMalignant Blood DisorderHematology	2016	144
Pharmacodynamics and Pharmacokinetics of AMG 531, a Thrombopoiesis‐Stimulating Peptibody, in Healthy Japanese Subjects: A Randomized, Placebo‐Controlled Study Yuji Kumagai, Tomoe Fujita, Machiko Ozaki, The Journal of Clinical Pharmacology ImmunologyPharmacotherapyHealthy Japanese SubjectsInflammationThrombosis	2007	86
Indirect-response model for the time course of leukopenia with anticancer drugs* Hironobu Minami, Yasutsuna Sasaki, Nagahiro Saijo, Clinical Pharmacology & Therapeutics	1998	76
Phase 1 trial of denosumab safety, pharmacokinetics, and pharmacodynamics in Japanese women with breast cancer–related bone metastases Kan Yonemori, Yasuhiro Fujiwara, Hironobu Minami, Cancer Science	2008	61
Pharmacological Correlation between Total Drug Concentration and Lactones of CPT‐11 and SN‐38 in Patients Treated with CPT‐11 Y Sasaki, Yasushi Yoshida, Kenichi Sudoh, Japanese Journal of Cancer Research	1995	58
Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study Michinori Ogura, Yoshitaka Imaizumi, Naokuni Uike, The Lancet Haematology Dose-escalation StudyLymphoid NeoplasiaHematological MalignancyMedicinePeripheral T-cell Lymphoma	2016	58
Development of Pseudolymphoma of Liver Following Interferon-alpha Therapy for Chronic Hepatitis B. Tomoko Ohtsu, Yasutsuna Sasaki, Hiroshi Tanizaki, Internal Medicine	1994	51
Epstein-Barr virus (EBV) genome carrying monoclonal B-cell lymphoma in a patient with adult T-cell leukemia-lymphoma Kensei Tobinai, Tomoko Ohtsu, Masaki Hayashi, Leukemia Research Hematological MalignancyLymphoid NeoplasiaEpstein-barr VirusImmunologyHematology	1991	50
Factors Affecting the Pharmacokinetics of CPT-11: The Body Mass Index, Age and Sex are Independent Predictors of Pharmacokinetic Parameters of CPT-11 Toshimichi Miya, Tomoyuki Goya, Hirofumi Fujii, Investigational New Drugs ObesityMetabolic SyndromeBody CompositionMedicineBody Mass Index	2001	45
Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab Tadahiko Igarashi, Tomoko Ohtsu, Hirofumi Fujii, International Journal of Hematology Lymphoid NeoplasiaMedicineImmunotherapyOncologyRadiation Oncology	2001	39

Page 1